行业视角看机构调研情况: 机械设备、电子、环保的调研热度有所上升 jianyuhan@kysec.cn 证书编号：S0790525050005 "机构调研信息"是投资者决策过程当中，重要的信息补充 机构调研是资本市场信息传递和价值挖掘的重要环节。对于专业机构而言，是深 度研究、投资决策的关键步骤。相较财务信息，机构调研具备披露及时、信息多 维且深入等优势。往往在调研结束后 1-2 天内，公司以公告方式对外披露，主要 内容包含参会人员信息、会议问答等，投资者与公司管理层之间的问答往往涉及 行业最新动态及公司运营细节。 机构调研信息是对基本面信息的重要补充，但信息量大且杂乱。为了清晰梳理 出调研中有效、增量信息，我们推出机构调研周跟踪系列，汇总最近一周、一 个月公开的机构调研信息，涵盖行业、个股两维度，包含调研热度（环比、同 比数据）、调研获得的行业及个股信息增量。 2026 年 01 月 13 日 机构关注度环比回升：机械设备、电子、环保 策略研究团队 ——机构调研周跟踪 韦冀星（分析师） 简宇涵（分析师） weijixing@kysec.cn 周度：上周，全 A 的被调研总次数环比持续下跌，且低于 2024 ...

Investment Rating - The report assigns a rating of "Buy" for the company [3]. Core Insights - The company has a solid foundation in polymer materials and thermal management, with a strong management team and extensive industry experience. The high-frequency welded liquid cooling plates for new energy thermal management have shown significant growth due to their adoption in Kirin and Shenxing batteries [1][7]. - The company is in the early stages of developing its data center thermal management business, with plans to acquire Dongguan Zhaoke, a leading thermal materials company, which is expected to create synergies with its existing operations [1][7]. - The trend towards liquid cooling in data centers is driven by the increasing power density of servers, making it a preferred solution for high-performance computing environments [1][7]. Financial Performance - The company expects total revenue to grow from 559 million RMB in 2023 to 3,583 million RMB by 2027, with a compound annual growth rate (CAGR) of approximately 65% [2]. - The projected net profit for 2025 is 50 million RMB, increasing to 200 million RMB by 2027, reflecting a strong growth trajectory [8]. - The company reported a significant increase in revenue from its thermal management business, which reached 311 million RMB in the first half of 2025, a 95% year-on-year increase [19]. Business Overview - The company specializes in polymer materials and thermal management systems, with products widely used in telecommunications, power, automotive, and data center sectors. Its polymer materials include waterproof sealing materials, fire insulation materials, and automotive sealing strips [7][14]. - The thermal management segment is primarily driven by its subsidiaries, focusing on new energy vehicles, energy storage systems, and data center cooling solutions [16][18]. - The company has established long-term partnerships with major clients in various industries, including Huawei, China Mobile, and major automotive manufacturers [30][32]. Growth Potential - The acquisition of Dongguan Zhaoke is expected to enhance the company's capabilities in the thermal management sector, particularly in data centers, where demand for thermal solutions is rapidly increasing [1][47]. - The company is actively investing in research and development to maintain its competitive edge, with a focus on optimizing material formulations and manufacturing processes [25][27].

Group 1 - The explosion at the Kaohsiung Hsingta Power Plant's new unit 2 has raised significant concerns, with initial investigations pointing to a loose flange in the gas pipeline as the cause of natural gas leakage [1][3] - Allegations have emerged claiming that certain suppliers have been selling low-quality parts from mainland China as original equipment to Taiwan Power Company (Taipower), but Taipower has clarified that their suppliers are from Australia, South Korea, and Singapore, denying any involvement of mainland manufacturers [3][6] - Taipower has committed to a thorough investigation and will hold responsible parties accountable based on the final report and contractual obligations [3] Group 2 - The explosion occurred on the evening of September 9, with significant fire and noise reported from a distance of approximately one kilometer, prompting a large-scale emergency response from local fire departments [6] - Public reactions include skepticism towards the allegations of substandard mainland parts, with some commentators questioning the lack of evidence and suggesting that installation issues may be the real problem [4][5]

Core Viewpoint - Shandong Linuo Pharmaceutical Packaging Co., Ltd. (301188.SZ) reported steady growth in its half-year performance for 2025, with revenue of 499 million yuan and a net profit of 40.97 million yuan, while enhancing its production capacity for borosilicate pharmaceutical glass and pursuing external growth strategies through acquisitions and joint ventures [1][2]. Group 1: Financial Performance - The company achieved an operating income of 499 million yuan and a net profit attributable to shareholders of 40.97 million yuan during the reporting period [1]. - Total assets at the end of the period amounted to 2.537 billion yuan [1]. Group 2: Production Capacity Enhancement - The production capacity for borosilicate pharmaceutical glass has been further increased, with the first furnace of the lightweight pharmaceutical molded glass bottle project having been ignited and put into production in February 2025 [2]. - The company is continuously increasing its production equipment for borosilicate tubular bottles to meet the growing demand from downstream customers, thereby expanding its market share in the pharmaceutical packaging sector [2]. Group 3: External Growth Strategies - The company has identified external growth as a key strategy for 2025, focusing on investing in quality enterprises in the pharmaceutical packaging field to broaden its product range [3]. - On August 19, the board approved a cash acquisition of 30% equity in Suzhou Chuangyang New Materials Technology Co., Ltd. for 84 million yuan, which will enhance the company's service capabilities by integrating plastic packaging materials with its existing glass offerings [3]. - A joint venture with Linuo Group is planned, with an investment of 92.65 million yuan to establish Linuo Innovation Technology (Shanghe) Co., Ltd., aimed at creating a high-end pharmaceutical packaging industry platform [3]. Group 4: Global Expansion - The company is focusing on global expansion, having conducted market assessments in regions such as Saudi Arabia, Brazil, and Southeast Asia, and signed a cooperation investment agreement with SANTISA in March 2025 [4]. Group 5: Financial Stability and Future Prospects - The company reported a net cash outflow from operating activities of 96.05 million yuan, primarily due to increased raw material inventory and slower sales collection [5]. - With a cash balance of 537 million yuan and a low debt ratio of 37.1%, the company has sufficient leverage for future expansion [5]. - The growing demand for high-quality packaging materials in the pharmaceutical industry, particularly for borosilicate glass, positions the company to strengthen its leading market position [5].

Core Viewpoint - Shandong Linuo Pharmaceutical Packaging Co., Ltd. reported a revenue of 499 million yuan and a net profit of 40.97 million yuan for the first half of 2025, while facing external pressures such as weak terminal demand and declining product prices. The company aims to stabilize operations, improve efficiency, and pursue expansion through both its core business and external acquisitions [1][5]. Group 1: Business Performance - The company achieved a total asset value of 2.537 billion yuan by the end of the reporting period [1]. - The production capacity of borosilicate pharmaceutical glass has been further enhanced, with the first kiln of the lightweight molded glass bottle project having been put into operation in February 2025 [1]. - The increase in production capacity is expected to meet the growing demand from downstream customers and expand the company's market share in the pharmaceutical packaging sector [1]. Group 2: Brand Development and Transformation - The company is accelerating its transformation towards self-owned brands, having established an e-commerce company in Hangzhou to promote its domestic brand "LEBOLEBO" and international brand "brohouse" [3]. - Since 2025, the company has been enhancing its internal design capabilities to launch fashionable glass products that cater to younger consumers, transitioning from an OEM to an ODM model [3]. Group 3: External Expansion and Strategic Investments - The company plans to invest in high-quality enterprises in the pharmaceutical packaging sector as part of its external development strategy for 2025, aiming to broaden its product range and provide one-stop procurement for pharmaceutical clients [3]. - The company has conducted assessments in regions such as Saudi Arabia, Brazil, and Southeast Asia, and signed a cooperation investment agreement with SANTISA in March 2025 [3]. Group 4: Joint Ventures and Acquisitions - The company announced a joint investment of 92.65 million yuan with Linuo Group to establish Linuo Innovation Technology (Shanghe) Co., Ltd., focusing on revitalizing idle land resources and creating a high-end pharmaceutical packaging industry platform [5][7]. - The company plans to acquire a 30% stake in Suzhou Chuangyang New Materials Technology Co., Ltd. for 84 million yuan, which will enhance its service capabilities by integrating plastic packaging materials with its existing glass offerings [7]. Group 5: Financial Health - The company reported a net cash outflow of 96.05 million yuan from operating activities due to increased raw material inventory and slower sales collection [8]. - The company maintains a cash reserve of 537 million yuan, which, along with unused fundraising and bank credit, is sufficient to cover convertible bond repayments, project construction, and acquisition funding needs [8]. - The debt-to-asset ratio stands at 37.1%, indicating a relatively low level compared to the industry, allowing for ample leverage for future expansion [9].